Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

INKT MiNK Therapeutics Inc

0,8604

-0,0266 (-3,00%)

07 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

MiNK Therapeutics (NASDAQ:INKT)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more MiNK Therapeutics Charts.

MiNK Therapeutics (NASDAQ:INKT)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more MiNK Therapeutics Charts.

News MiNK Therapeutics Inc

Form DEF 14A - Other definitive proxy statements
Freitag 20 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

MiNK Therapeutics to Present iNKT Cell Therapy in Gastric Cancer at ASCO GI Annual Meeting
Mittwoch 18 Dezember 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Montag 9 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Montag 9 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Freitag 6 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 3 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update
Donnerstag 14 November 2024 (2 Monate vor) • GlobeNewswire Inc.

MiNK Therapeutics to Provide Corporate Update and Third Quarter 2024 Financial Report
Montag 11 November 2024 (2 Monate vor) • GlobeNewswire Inc.

MiNK’s iNKT Cell Therapy Shows Potential for Optimal Multi-Combination for Resistant Solid Cancers at SITC 2024
Donnerstag 7 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 31 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere MiNK Therapeutics Inc News-Artikel

BNP Paribas (QX)

JP Morgan Chase

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen